Some people respond better to one than the other depending on their body and goals
Neither does your doctor, to be fair
Yes, patients with well-controlled Hashimoto's thyroiditis on stable levothyroxine therapy can generally use tirzepatide when indicated for type 2 diabetes or obesity management
A compounding pharmacy can fine-tune your tirzepatide dose in smaller increments useful for easing past side effects or dialing in the exact amount that breaks your plateau without overshooting
Then, lower your tongue and hold the liquid there without swallowing
This multi-dimensional therapeutic potential is reshaping the positioning of GLP-1 drugs as comprehensive metabolic treatments rather than just glucose-lowering agents For instance, Novo Nordisks semaglutide is now marketed as Wegovy specifically for chronic weight management, while Eli Lillys tirzepatide has received FDA approval under the brand name Zepbound for obesity treatment, independent of diabetic status